GlobalData on MSN2d
SolasCure initiates Phase II trial of chronic wound treatment gelUK biotechnology company SolasCure has commenced the randomised, controlled CLEANVLU2 Phase II trial of Aurase Wound Gel for ...
An inquest has been opened at Norfolk Coroner's Court after day-old Thiyash Thajeepan died at the James Paget Hospital.
News-Medical.Net on MSN3d
Solascure enrols first patient in a next phase II clinical trial to advance Aurase Wound GelSOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today ...
Ad-hoc announcement pursuant to Article 53 of the SIX listing rulesKuros Biosciences grows sales to CHF 75.6 million for 2024Financial ...
SolasCure, a Cambridge biotech developing a novel treatment to transform chronic wound healing, has initiated a new Phase II ...
Speaking of conversations, let’s dive into the hottest topics that stole the spotlight at IMCAS 2025—insights that inspire ...
Ad-hoc announcement pursuant to Article 53 of the SIX listing rules Kuros Biosciences grows sales to CHF 75.6 million for 2024 Financial Highlights Direct MagnetOs sales increased by 136% to ...
Roche’s Genentech unit has received approval from the US Food and Drug Administration (FDA) for TNKase (tenecteplase) in acute ischaemic stroke (AIS). The drug, which has been authorised for use in ...
Irish Independent on MSN8d
Ask the doctor: I have a family history of blood clots. Is HRT an option for me?Question: There is a strong history of blood clots in my family and I was prescribed the progesterone only pill as a result.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback